Exhibit
4.4


 


[NOTE
ABOUT TRANSLATION: This document is an English translation of a document in Italian language. In preparing this document, an attempt
has been made to translate as literally as possible without jeopardizing the overall continuity of the text. Inevitably, however, differences
may occur in translation and if they do, the Italian text will govern by law. In this translation, Italian legal concepts are expressed
in English terms and not in their original Italian terms. The concepts concerned may not be identical to concepts described by the English
terms as such terms may be understood under the laws of other jurisdictions]


 


SUBSCRIPTION
OF ORDINARY SHARES OF GENENTA SCIENCE S.P.A.


WHEREAS


 


	 	●	In
    the context of the process of listing the ordinary shares of Genenta Science S.p.A. (the Company), represented by American
    Depositary Shares, on the U.S. Nasdaq Capital Market, on May 20, 2021, the extraordinary Shareholders’ Meeting of the Company
    has authorized a specific capital increase, with the exclusion of the pre-emption right, to service the transaction;
	 	●	the
    offering of the securities (the Offering) is being made pursuant to an effective registration statement (Form F - 1) (the
    Registration Statement) filed by the Company with the Securities and Exchange Commission (the Commission) (including
    the prospectus contained therein) (the Prospectus), Prospectus subject to U.S. regulation, containing information regarding
    the securities and the terms of the Offering that has been or will be filed with the Commission and made available to the Shareholder,
    as defined below, by the filing by the Company of an electronic version thereof with the Commission;
	 	●	in
    the context of this Offering, a tranche of newly issued ordinary shares was reserved for subscription by the Company’s existing
    shareholders (the Reserved Offering);
	 	●	the
    Reserved Offering falls within the cases of inapplicability of the provisions on public offerings of securities provided for in section
    100 of Legislative Decree no. 58 of 24 February 1998 (the Consolidated Law on Finance), section 34-ter, of the issuers’
    regulations adopted with CONSOB resolution no. 11971 of 14 May 1999 (the Issuers’ Regulation) and section 1, paragraph
    4, of Regulation (EU) 2017/1129 (the Prospectus Regulation).


 


WHEREAS


 


The
undersigned___________________________ (the Shareholder), fiscal code no.____________________________


 


REPRESENTS


 


	 	●	to
    be a Shareholder of the Company;
	 	●	[to
    be a “qualified investor” as defined in the Prospectus Regulations pursuant to Article 2(e);] [Note:
    this declaration shall be deleted if the Shareholder is not a qualified investor]
	 	●	that
    he/she/it has examined, by access to the following link __________ , the preliminary Prospectus dated _______ 2021 and the final
    Prospectus dated ______ 2021, each of which is included in the Registration Statement; and
	 	●	that
    he/she/it has acknowledged and understood the contents of the Prospectus and fully accepts the terms and conditions of the Prospectus;


 


REPRESENTS
and UNDERTAKES


 


	 	●	to
    subscribe ______ newly issued ordinary shares of the Company, forming part of the Reserved Offering, with no par value (the Shares),
    for an aggregate purchase price of EUR _____ (the Aggregate Purchase Price);
	 	●	to
    pay, with a value date of ______ 2021, the Aggregate Purchase Price by wire transfer to the bank account no. ______________________
    held by the Company at ____________IBAN______________________________;


 


***


The
Shares must be registered as follows:


 


	 	●	Fiscal
    code_____________________________________________
	 	●	First
    name, last name, company name_____________________________________________
	 	●	Date
    and place of birth__________________________________
	 	●	Nationality__________________________________
	 	●	Domicile
    or registered office__________________________________
	 	●	Postal
    Code__________________________________


 


***


 




    	 



    	 



    

 


	The
    undersigned	 
	REPRESENTS	to
    be informed that this subscription is irrevocable;
	REPRESENTS	that
    he/she/it has independently evaluated the possibility of subscribing the Shares that are part of the Reserved Offering; (ii) that
    he/she/it is not (a) domiciled in the United States of America, (b) a U.S. Person as defined in Regulation S under the United States
    Securities Act of 1933, as subsequently amended, and (iii) that he/she/it is not acting on behalf of or for the benefit of a U.S.
    Person;
	RECOGNISES	expressly
    the right of the Company to reject this subscription without the undersigned having any claim for damages or compensation against
    the Company, if the Offering is withdrawn for any reason and that this subscription is conditional upon the successful completion
    of the Offering;
	TAKES
    NOTE	that
    the allocated Shares will be centralised in dematerialised form at Monte Titoli S.p.A.;
	REQUESTS

     
	that
    the Shares will be credited to deposit account no. ___________ at __________________ (name of the intermediary with which the Shareholder
    holds the Shares of the Company);
	CONFIRMS	under
    its own responsibility, for all legal purposes, the accuracy of the information reported in this subscription;
	REPRESENTS	to
    be informed that any irregularity in this subscription will lead to its cancellation;
	CONFIRMS	that
    he/she/it has expressly requested that all documents evidencing or relating in any way to the Reserved Offering (other than this
    subscription or any related notice) be drawn up in the English language only; and
	REPRESENTS	to
    be informed that this subscription shall be governed by and interpreted in accordance with Italian law and that any dispute arising
    in connection with the execution and interpretation of this subscription shall be subject to the exclusive jurisdiction of the Court
    of Milan, without prejudice to the mandatory jurisdiction established by law.


 


	____________________________

    (Date
    and time)
	____________________________

    (Signature
    of the applicant)
	____________________________

    (Signature
    of the Company)